These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36360415)

  • 1. Timing of Systemic Steroids and Neurodevelopmental Outcomes in Infants < 29 Weeks Gestation.
    Kandraju H; Jasani B; Shah PS; Church PT; Luu TM; Ye XY; Stavel M; Mukerji A; Shah V; The Cnn Investigators ; The Cnfun Investigators
    Children (Basel); 2022 Nov; 9(11):. PubMed ID: 36360415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
    Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates.
    Kelly EN; Shah VS; Levenbach J; Vincer M; DaSilva O; Shah PS;
    J Matern Fetal Neonatal Med; 2018 Oct; 31(20):2665-2672. PubMed ID: 28714339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between intermittent hypoxemia and neurodevelopmental outcomes in extremely premature infants: A single-center experience.
    Kim F; Bateman DA; Garey D; Goldshtrom N; Isler JR; Sahni R; Wallman-Stokes A
    Early Hum Dev; 2024 Jan; 188():105919. PubMed ID: 38118389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of developmental outcomes in a very preterm Canadian cohort.
    Synnes A; Luu TM; Moddemann D; Church P; Lee D; Vincer M; Ballantyne M; Majnemer A; Creighton D; Yang J; Sauve R; Saigal S; Shah P; Lee SK;
    Arch Dis Child Fetal Neonatal Ed; 2017 May; 102(3):F235-F234. PubMed ID: 27758929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal age and long-term neurodevelopmental outcomes of preterm infants < 29 weeks gestational age.
    DiLabio J; Zwicker JG; Sherlock R; Daspal S; Shah PS; Shah V;
    J Perinatol; 2021 Jun; 41(6):1304-1312. PubMed ID: 32694856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity: A Meta-analysis.
    Tsai CY; Yeh PT; Tsao PN; Chung YE; Chang YS; Lai TT
    Ophthalmology; 2021 Jun; 128(6):877-888. PubMed ID: 33212122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading of Intraventricular Hemorrhage and Neurodevelopment in Preterm <29 Weeks’ GA in Canada.
    Shah V; Musrap N; Maharaj K; Afifi J; El-Naggar W; Kelly E; Mukerji A; Shah P; Vincer M;
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal and Neurodevelopmental Outcomes Following Linezolid for Coagulase-negative Staphylococcal Infection: Real World Evidence.
    Sicard M; Moussa A; Barrington K; Martin B; Luu TM; Ting JY; Roberts A; Paquette V; Shah PS; Kelly E; Autmizguine J
    Pediatr Infect Dis J; 2020 Jul; 39(7):598-603. PubMed ID: 32091496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal infection and neurodevelopmental outcomes at 18-30 months in preterm infants.
    Zhou Q; Kelly E; Luu TM; Ye XY; Ting J; Shah PS; Lee SK
    Front Pediatr; 2023; 11():1145252. PubMed ID: 37152326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal acetaminophen exposure and neurodevelopmental outcomes at 18-21 months corrected gestational age in preterm infants <29 weeks gestation: a retrospective cohort study.
    Srajer A; Roychoudhury S; Tang S; Hasan SU; Momin S; Hendson L; Alshaikh B; Yusuf K
    Pediatr Res; 2023 Dec; ():. PubMed ID: 38057580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age.
    Choi EK; Shin SH; Kim EK; Kim HS
    BMC Pediatr; 2019 Jan; 19(1):26. PubMed ID: 30654786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab and neurodevelopmental outcomes of preterm infants with retinopathy of prematurity: should we still worry?
    Celik P; Ayranci Sucakli I; Kara C; Petricli IS; Kavurt S; Celik IH; Bas AY; Demirel N
    J Matern Fetal Neonatal Med; 2022 Feb; 35(3):415-422. PubMed ID: 33618591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.